30th Cardiovascular Surgical Symposium – CSS
15.30 – 18.30 Interactive Cardiovascular Training for Residents
15.30 – 16.00 Aortic valve disease: the view of the cardiologists
16.00 – 16.30 Aortic valve disease: the view of the surgeon
S. Folkmann, T. Fleck, M. Grabenwöger (Vienna)
Wetlab: Aortic valve replacement and coronary artery bypass grafting
18.30 Welcome Reception at the congress venue for al participants of the meeting
9.00 – 12.00 Interactive Cardiovascular Training for Residents
9.00 – 9.30 Practical aspects of PM-insertion
9.30 – 10.00 How to train cardiac surgeons
S. Folkmann, M. Gorlitzer, G. Laufer (Vienna)
Aortic valve replacement and coronary artery bypass grafting
30th Cardiovascular Surgical Symposium – CSS
SUNDAY, March 4, 2012 – SCIENTIFIC PROGRAM
G.Laufer, M. Grabenwöger, M. Deutsch (Vienna)
15.30 – 17.00 Session A: Cardiac Arrhythmias: Incidence and Diagnosis
Chair: M. Brunner (Vienna), V. Falk (Zurich)
• State-of-the-art: PM-therapy for SSS und AV-block
• Ventricular arrhythmias and defibril atortherapy
PRO-CON SESSION:
• Pacemakers should be implanted by surgeons
• Pacemaker should be implanted by cardiologist
17.30 – 19.00 Session B: Coronary Artery Disease
Chair: M .Grabenwöger (Vienna), G. Laufer (Vienna)
UPDATE ON THE SYNTAX TRIAL: KEYNOTE LECTURE:
• Guidelines for the treatment of coronary artery disease:
30th Cardiovascular Surgical Symposium – CSS
MONDAY, March 5, 2012 – SCIENTIFIC PROGRAM
Chair: M. Grimm (Innsbruck), W. Wandschneider (Klagenfurt)
• Intraoperative, autologous CD133+ stem cel isolation
and TMLR-supported transplantation during CABG
• The prevention and management of severe complications
during congenital heart disease interventions
• Should all moderate coronary lesions be grafted during primary
coronary bypass surgery? An analysis of disease progression during angiographic surveil ance in a trial of conduits
• Risk stratification model and internal mammary artery grafting in patients undergoing
coronary artery bypass surgery within 24 hours of a myocardial infarction
• First successful postoperative activation of enCor SQ
• Factors influencing the choice for endoscopic vein harvesting
in patients undergoing coronary artery bypass grafting: a single center experience
• Human vascular organ culture under flow conditions
• CPB-assisted PCI in high risk patients with multivessel coronary disease
• Emergency coronary artery bypass surgery -
• Revascularization of occluded or stenotic subclavian
veins is supported by laser lead extraction
• Novel new rotary VAD to address the economic limitations on destination therapy S. Westaby (Oxford)
• Study on decellularized porcine pulmonary valved conduits
• Isolated right coronary artery fistula to left ventricle:
• Coronary arteries aneurysms associated with
giant bilateral aneurysms of Iliac arteries. Case report
• The Medtronic 3830 SelectSecure pacing lead is safe
and favorable in pediatric pacemaker patients
• Laser enhanced technique for lead extraction
• Tear orientated aortic dissection surgery yields
both low operative mortality and reoperation rate
• Elective transfer from cardiopulmonary bypass to centrifugal
pump support in very high risk cardiac surgery
• Aortic valve replacement in patients 80 years of age and older
30th Cardiovascular Surgical Symposium – CSS
MONDAY, March 5, 2012 – SCIENTIFIC PROGRAM
14.00 – 15.30 Postoperative Care in Cardiac Surgery sponsored by POSTHORAX
Chair: S. Folkmann (Vienna), M. Gorlitzer (Vienna)
• Wire fixation versus rigid titanium plate after sternotomy –
results of a randomized, prospective, multi-center international trial
• Elimination of deep and superficial sternal wound infection
• POSTHORAX vest: Biomechanical analysis supports clinical findings
15.30 – 17.00 Session A: Pacemaker Therapy 1
Chair: C. Khazen (Vienna), F. Hintringer (Innsbruck)
• Biventricular pacing: Current status
• Technical aspects of biventricular stimulation
• Multipolar left ventricular stimulation
17.30 – 19.00 Session B: Pacemaker Therapy 2
Chair: M. Gaspar (Timisoara), F. Veit (Vienna)
• Lead extraction today: potential hazards and benefits
• Alternate lead placement for biventricular stimulation
KEYNOTE LECTURE:
• 30 years of Cardiovascular Symposium Zürs –
30th Cardiovascular Surgical Symposium – CSS
TUESDAY, March 6, 2012 – SCIENTIFIC PROGRAM
8.15 – 11.00 Aortic Valve Symposium sponsored by SYMETIS
Chair: T. Fischlein (Nuremberg), R. Seitelberger (Salzburg)
• The future of transapical aortic valve implantation
• Sutureless valves in the times of TAVI
• Rheumatic valve disease – the plight of mil ions
• Off-pump transapical mitral valved stent implantation
• Transcatheter aortic valve implantation versus surgical
aortic valve replacement: a propensity score matched analysis in patients at high surgical risk
• Clinical experience with second-generation devices for
transcatheter aortic valve implantation – any advantages compared to first generation devices?
• Right-sided minitoracotomy vs. full sternotomy approach for
• Predictive value of plasma neutrophil gelatinase-associated
lipocalin for acute kidney injury in aortic valve replacement patients
• Is there any relationship between aortic stiffness and
B-type natriuretic peptide in patients with aortic stenosis?
• Dramatic ventricle rupture after extended papil ary muscle
• Prospective study of 7-day Holter tape follow-up of
patients undergoing concomitant atrial fibril ation with high intensity focused ultrasound
30th Cardiovascular Surgical Symposium – CSS
TUESDAY, March 6, 2012 – SCIENTIFIC PROGRAM
14.00 – 15.30 Simulation Training in Cardiac Surgery
15.30 – 17.00 Session A: Atrial Fibrillation 1
Chair: K. Huber (Vienna), A. Marmureanu (Los Angeles)
• Standard and new anticoagulants for AFib
• Catheter ablation and hybrid approach
• Subxyphoidal hybrid approach for AFib
• Surgical AF ablation: State-of-the-art
17.30 – 19.00 Session B: Atrial Fibrillation 2
N. Ad (Fal s Church), F.X. Roithinger (Mödling)
• Surgical exclusion of the LAA: Resection or occlusion
• Minimal invasive approaches for LAA occlusion
• LAA closure with Amplatzer technology
• Watchmann device und PROTECT-AF Trial
30th Cardiovascular Surgical Symposium – CSS
WEDNESDAY, March 7, 2012– SCIENTIFIC PROGRAM
Chair: M. Deutsch (Vienna), E. Wolner (Vienna)
• Risk factors for coronary heart disease in connective tissue diseases
• Anterolateral thoracotomy for mitral valve replacement
• Midterm results after aortic valve repair by tricuspidalisation and
replacement of the right coronary cusp by autologous pericardium
• Healthcare disparities in cardiac surgery
• Economic aspects of deep sternal wound infections
• From appendicitis to aortic valve endocarditis- a delayed destruction of the AV
• Thoracoscopic surgical patch insulation of the phrenic
nerve as a novel strategy to correct diaphragmatic twitch secondary to cardiac resynchronization therapy
• Video-assisted thoracoscopic implantation of left ventricular
epicardial leads for ventricular resynchronization
• Atrial fibril ation after coronary bypass surgery –
• Skeletal Manifestations of the Marfan Syndrome
• Mitral valve reconstruction after giant atrial myxoma mechanical damages
• An audit of endotracheal cuff pressures on
admission to cardiac surgical intensive care
• Epoprostenol use in patients with a history of heparin induced Thrombocytopenia:
An alternative to thrombin inhibition but significantly cheaper
• ROSS operation in patients with bicuspid aortic valve:
• Over five years experience with the stentless Sorin Freedom Solo Aortic
30th Cardiovascular Surgical Symposium – CSS
WEDNESDAY, March 7, 2012– SCIENTIFIC PROGRAM
14.00 – 15.30 Training in Cardiac Surgery
15.30 – 17.00 Session A: Connective Tissue Disease 1
Chair: H. Reichenspurner (Hamburg), A. Repossini (Brescia)
• Rationale for drug therapy and molecular biological
strategies for causative treatment of Marfan Syndrome
• Mitral valve disease in patients with Marfan Syndrome
• Minimal y invasive Mitral repair in Barlow disease
• The David operation in Marfan patients
• Pediatric manifestations of the Marfan Syndrome
17.30 – 19.00 Session B: Connective Tissue Disease 2
Chair: R. De Paulis (Rome), E. Weigang (Mainz)
• The role of stent graft therapy for Marfan Syndrome
• Elective Surgery for aortic aneurysms in Marfan patients: When and how
• Aortic dissections in Marfan patients
• Aortic root disease in patients with Marfan Syndrome
30th Cardiovascular Surgical Symposium – CSS
THURSDAY, March 8, 2012 – SCIENTIFIC PROGRAM
Chair: T. Fleck (Vienna), G. Weiss (Leipzig)
• Update in techniques for lung separation
• Studying the effects of treatment methods in patients with
atherosclerosis and kinking of carotid artery
• Recovery after long-term pulsatile mechanical circulatory
support in patient with chronic heart failure: a bridge too far?
• Matrix-based repair of acute Type-A aortic dissections
as an alternative to conventional glue repair
• Superior vena cava atresia caused by Behcet’s disease, a trap with caution
• Belorussian experience in mechanical circulatory support
• Mechanical circulatory support in children with left ventricular and
biventricular assist devices as a bridge to heart transplantation
• Focusing on pump thrombosis – contributing factors of
chamber change after assist device implantation
• Studying the significant role of combined product of Methyluracil and
Chloramphenicol in the treatment of lower extremity ischemic ulcers in patients with peripheral arterial disease
• Heart echinococcosis: new data - new questions
• One-stage complete repair of thoracic aorta including aortic valve – a case report
• Impact of etiology of mitral regurgitation (MR) on outcome
after interventional mitral valve repair using the MitraClip system
30th Cardiovascular Surgical Symposium – CSS
THURSDAY, March 8, 2012 – SCIENTIFIC PROGRAM
14.00 – 15.30 EuRADa – European Registry of Aortic Disease
15.30 – 17.00 Session A: Principles of Long-term Support
Chair: E. Potapov (Berlin), D. Zimpfer (Vienna)
• Nine years of ventricular assist device program in IKEM
17.30 – 19.20 Session B: Devices for Long-term Support
Chair: U. Livi (Udine), H. Schima (Vienna)
KEYNOTE LECTURE:
• 30 years of mechanical circulatory support
30th Cardiovascular Surgical Symposium – CSS
FRIDAY, March 9, 2012 – SCIENTIFIC PROGRAM
Chair: S. Folkmann (Vienna), E. Weigang (Mainz)
• Low rate of bleeding events under a mild anticoagulation regimen
in the use of the HeartMate II left ventricular assist device
• Exercise hemodynamics and quality of life after
• The outcome in octogenarians after cardiac surgery
• Endovascular exclusion of a glass shaped saccular aneurysm with
Endologix stent graft in a very high risk patient
• Intraoperative assessment of blood flow using the
new ICG imaging system in cardiovascular surgery
• Characteristics of TAV- and BAV-associated thoracic aortic aneurysms –
smooth muscle cel biology, expression profiling, and histological analyses
• TEVAR in Aortic type B dissection - impact of
• Outcome of aortic valve sparing by reimplantation in patients with
aortic regurgitation and dilatation of the ascending aorta. The role of the echocardiographic evaluation
• ECMO in pregnancy as poor prognostic factor: A single center experience
• Rewarming of accidental hypothermic cardiac arrest with extra-corporeal circulation.
• Actual state of circulatory support systems in pediatrics
• Short-term ventricular assist device as a bridge to transplantation
• Update of mechanical circulatory support: experiences
30th Cardiovascular Surgical Symposium – CSS
FRIDAY, March 9, 2012 – SCIENTIFIC PROGRAM
• Surgeons fear of a corpus alienum: Re-sternotomy as an unwelcome
side-effect of unknown fizzy tablet intake?!
• Pulmonary atresia with ventricular septal defect and major aortopulmonary
col ateral arteries: outcome improvement
• Endoprosthesis for thoraco-abdominal Typ-B dissection scarce distal landingzone
• Effect of diastolic dysfunction on the outcome of coronary bypass grafting surgery;
• Case study: aortic insufficiency, caused by rare anatomical feature
• An unusual aortic valve sparing: David ‘reimplantation’ and cusp extension
Chair: S. Folkmann (Vienna), M. Gorlitzer (Vienna)
15.30 – 17.00 Session A: Extracorporeal Membrane Oxygenation
Chair: A. Rajek (Vienna), C. Schmid (Regensburg)
• Percutaneous VA ECMO for acute resuscitation
• ECMO support in the pediatric population
17.30 – 19.00 Session B: Short- and Long-term Support
Chair: M. Strüber (Vienna), G. Trittenwein (Vienna)
• Resuscitation for avalanche accidents
Prescription Program Drug list — To be used by members who have a formulary drug plan. Anthem Blue Cross California prescription drug benefits include medications available on the Anthem Drug List. Our prescription drug benefits can offer potential savings when your physician prescribes medications on the drug list. For more information about your drug plan, you can do A. The Anth
WEST CHESTER G.I. ASSOCIATES Procedure Date: _______/______/______ Bowel Preparation with Gatorade, Dulcolax & Miralax □ DO NOT EAT OR DRINK ANYTHING 4 HOURS BEFORE YOUR SCHEDULED ARRIVAL TIME. □ You must be accompanied by a friend or relative to drive and/or assist you home. We WILL NOT discharge you to a cab, bus or other transportation service without a responsible